BANDIT: Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis

• Sponsor: University Hospital, Basel, Switzerland (Other)
• Overall Status: Not yet recruiting
• CT.gov ID: NCT06078345
• Collaborator: ETH Zurich (Switzerland) (Other)
• Enrollment: 30
• Location: 1
• Arms: 2
• Anticipated Duration (Months): 20.6
• Patients Per Site Per Month: 1.5

Study Details

Study Description

Brief Summary

To test the hypothesis that active BAT improves metabolic health by buffering postprandial metabolites plasma metabolites and energy expenditure will be compared in volunteers with and without active BAT. Both groups will receive test meals with protein, fat and carbohydrates separately, so that the individual impacts of these macronutrients on diet induced thermogenesis and the buffering function of BAT can be derived. BAT biopsies will be taken before and after the test meals for molecular analysis.

Condition or Disease	Intervention/Treatment	Phase
Brown Adipose Tissue; Metabolic Disease	Other: Carbohydrate; Other: Fat; Other: Protein	N/A

Detailed Description

In this prospective interventional study healthy individuals will be screened for presence of active BAT: Maximal BAT activity will be achieved by a mild cold stimulus over 2 hous and quantified by 18F-FDG-PET/CT 30 min after injection of 75 MBq of 18F-FDG.

Individuals with FDG-PET positive BAT will be included as BAT-positive subjects (n=15) and individuals with absence of FDG-positive BAT will be included as BAT-negative subjects (n=15) and then take part in three study visits in random order.

During the study visits participants will consume a standardized isocaloric liquid meal consisting of A) glucose (OGTT) B) fat and C) protein.

Energy expenditure will be measured by indirect calorimetry before as well as hourly after the meal for 5 hours. Blood samples will be taken before and at 30 minute intervals after the meal for 5 hours for analysis of blood glucose, triglycerides, FAAs, representative amino acids, insulin and noradrenaline.

Subjects will undergo ultrasound-guided biopsy of the supraclavicular fat depot in the fasting state and after one of the test meals so that biopsies from 5 individuals in each group after each test meal will be obtained.

Study Design

• Study Type: Interventional
• Anticipated Enrollment: 30 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Intervention Model Description: Prospective interventional trial in healthy volunteers with random sequence of the three study interventions.Prospective interventional trial in healthy volunteers with random sequence of the three study interventions.
• Masking: None (Open Label)
• Primary Purpose: Basic Science
• Official Title: Brown Adipose Tissue as Nutrient Buffer Through Diet Induced Thermogenesis
• Anticipated Study Start Date: Oct 12, 2023
• Anticipated Primary Completion Date: Jun 30, 2025
• Anticipated Study Completion Date: Jun 30, 2025

Arms and Interventions

Arm	Intervention/Treatment
Experimental: BAT positive Maximal activated supraclavicular BAT SUVmean >1,5 g/ml-	Other: Carbohydrate; 400 Kcal glucose (100g oGTT); Other: Fat; 400 Kcal glucose rapeseed oil.; Other: Protein; 400 Kcal Moltein PURE (111g)
Experimental: BAT negative Maximal activated supraclavicular BAT SUVmean <1,5 g/ml	Other: Carbohydrate; 400 Kcal glucose (100g oGTT); Other: Fat; 400 Kcal glucose rapeseed oil.; Other: Protein; 400 Kcal Moltein PURE (111g)

Outcome Measures

Primary Outcome Measures

1. AUC Glucose [1h before and 5 hours after nutritional intervention]

   Area under the curve (AUC) of glucose after the oral glucose load in participants with functional BAT as compared to participants without functional BAT

Secondary Outcome Measures

1. AUC Branched chain amino acids [1h before and 5 hours after nutritional intervention]

   AUC of BCAAs after protein load in in participants with functional BAT as compared to participants without functional BAT

2. AUC triglycerides [1h before and 5 hours after nutritional intervention]

   AUC of plasma triglycerides after lipid test meal in participants with functional BAT as compared to participants without functional BAT.

3. Diet induced thermogenesis [1h before and 5 hours after nutritional intervention]

   Diet-induced thermogenesis: AUC of EE above RMR in response to the respective macronutrient (carbohydrate, protein or fat). Measured by indirect calorimetry. The results for each macronutrient will be compared between the BAT positive and BAT negative participants.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 40 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• BMI 18.5 to 28 kg/m2

• Able to give informed consent as documented by signature

Exclusion Criteria:

• Concomitant medication other than prescription free analgesics (paracetamol and NSAID) and oral contraceptives

• Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, diabetes mellitus)

• Hyper- or hypothyroidism

• Smoker / habitual tobacco use

• Weight change of >5% within 3 months prior to inclusion

• Hypersensitivity to cold (e.g. Raynaud syndrome)

• Known or suspected non-compliance, drug or alcohol abuse

• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant

• Enrolment of the investigator, his/her family members, employees and other dependent persons

• Enrolment into another study using ionizing radiation within the previous 12 months

• Enrolment into another study including a pharmacological or nutritional intervention

• Pregnancy or lactation

• Lab parameters

• Serum-Creatinine: above 1.5x upper limit of normal (ULN)

• Glycated Hemoglobin (HbA1c): above 6.0%

• Random plasma glucose >11 mM

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University Hospital Basel, Dept. of Endocrinology	Basel		Switzerland

Sponsors and Collaborators

• University Hospital, Basel, Switzerland
• ETH Zurich (Switzerland)

Investigators

• Principal Investigator: Matthias J Betz, MD, University Hospital, Basel, Switzerland

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University Hospital, Basel, Switzerland
• ClinicalTrials.gov Identifier: NCT06078345
• Other Study ID Numbers: EKNZ 2023-01544
• First Posted: Oct 11, 2023
• Last Update Posted: Oct 11, 2023
• Last Verified: Oct 1, 2023

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by University Hospital, Basel, Switzerland: Diet induced thermogenesis; Cold exposure; Energy Expenditure
• Additional relevant MeSH terms: Metabolic Diseases

Study Results

No Results Posted as of Oct 11, 2023